BIT
Click for more information
0.00% 3.3¢ biotron limited

Ann: Significant Immunological Outcomes in BIT225 HIV-1 Trial, page-127

  1. Stretch83
    448 Posts.
    lightbulb Created with Sketch. 28
    clock Created with Sketch.
    01/10/18
    14:28
    Post #: 35950340
    BITOA doesn't seem a good buy to me with expiry next month. Will also mean you will be paying 6.5c at current prices.
    Either BIT or BITOB was my tussel.

    I went for OB myself. Can buy more with limited funds and pay later. has a lower exercise price over the 2 options as well.
    Depends on how you are positioned really
    BIT Price at posting: 4.9¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

FWD Queensland's housing crisis an opportunity for ASX builder Fleetwood – and taxpayer cash a safe harbour from the storm
right-arrow Created with Sketch.
TLX Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
right-arrow Created with Sketch.
NEWS ASX hits all time high out the gate on Friday trades following bullish US inflation data
right-arrow Created with Sketch.
NEWS Hillcrest Energy Unveils Power Factor Correction Prototype to Meet Growing Demand
right-arrow Created with Sketch.
BHP BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning
right-arrow Created with Sketch.
NEWS Buying smarter as baby boomers get boost
right-arrow Created with Sketch.
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
3.3¢ 		Change
0.000(0.00%) 		Mkt cap ! $29.77M
Open High Low Value Volume
3.4¢ 3.4¢ 3.1¢ $74.61K 2.300M

Buyers (Bids)

No. Vol. Price($)
4 280031 3.2¢
 

Sellers (Offers)

Price($) Vol. No.
3.4¢ 96500 1
View Market Depth
Last trade - 15.22pm 12/07/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.